Nothing Special   »   [go: up one dir, main page]

KR20170062043A - Emulsion type cosmetic composition comprising ceramide - Google Patents

Emulsion type cosmetic composition comprising ceramide Download PDF

Info

Publication number
KR20170062043A
KR20170062043A KR1020150167390A KR20150167390A KR20170062043A KR 20170062043 A KR20170062043 A KR 20170062043A KR 1020150167390 A KR1020150167390 A KR 1020150167390A KR 20150167390 A KR20150167390 A KR 20150167390A KR 20170062043 A KR20170062043 A KR 20170062043A
Authority
KR
South Korea
Prior art keywords
less
ceramide
group
anisotropic powder
polymer
Prior art date
Application number
KR1020150167390A
Other languages
Korean (ko)
Inventor
남진
피봉수
김영선
진유진
안순애
강병영
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020150167390A priority Critical patent/KR20170062043A/en
Publication of KR20170062043A publication Critical patent/KR20170062043A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to an underwater type emulsion cosmetic composition comprising an amphiphilic anisotropic powder and a ceramide, wherein the amphiphilic anisotropic powder comprises a first polymeric spheroid which is hydrophilic and a second polymeric spheroid which is hydrophobic, Wherein the first polymer spolide and the second polymer spolide are at least partially bound to a structure that penetrates the counterpart polymer spoloid, and wherein the first polymer spolide and the second polymer spolide comprise a (meth) acrylate-based polymer An oil-in-water emulsion cosmetic composition containing oil-based ceramide and oil-soluble ceramide particles contained in the oil-based oil.

Description

The present invention relates to an emulsion cosmetic composition comprising ceramide,

TECHNICAL FIELD The present invention relates to an emulsion cosmetic composition comprising ceramides and a method for producing the emulsion cosmetic composition.

Intercellular lipids have physiochemical effects on the skin. Intercellular lipids consist mainly of ceramides, fatty acids, cholesterol and cholesterol esters, among which ceramides account for about 40% to 60%. Ceramides play an important role in the intercellular lipid structure and barrier function. Ceramides are treated within the formulation cosmetic formulations due to the van der Waals attraction between the non-polar tail and the intermolecular hydrogen bonds caused by the amido-carbonyl group and the hydroxyl group of the polar head group It has a tricky characteristic. Pseudoceramides also have a unique thermal behavior due to the geometric structure of the molecule and the hydrogen bonding of the head group, making it difficult to control the prescription design and manufacturing process.

The size and shape of the spherical fine particles made of the polymer are controlled according to the manufacturing method, and thus the application possibility is expanded. One of its applications is Pickering emulsion which can form stabilized macroporous particles using micro spherical particles. O / W emulsified particles are formed at a contact angle of 90 ° or more, and W / O emulsion particles are formed at a temperature of 90 ° or less depending on the degree of hydrophilicity / hydrophobicity of the spherical particles.

Attempts have been made to produce new anisotropic powders by imparting amphiphilic properties, both hydrophilic and hydrophobic, to the microspheres. An example is the Janus spherical particles. However, due to the morphological limitations of these spheres, there is a limit to the chemical anisotropy. In other words, although it is morphologically anisotropic, it is totally hydrophobic or hydrophilic, so that there is a limit to chemical anisotropy.

It has been attempted to produce anisotropic powders having surface activity by imparting chemical anisotropy together with geometric shape control. However, despite the advantage of its applicability of amphiphilic anisotropic powder, up to now, Has not been specifically developed, and there is a problem that it is difficult to mass-produce uniformly in the industry, so that no practical industrial application has been made.

The prior art of the present invention is disclosed in Korean Patent Publication No. 1997-0025588.

In view of the above, a problem to be solved by the present invention is to provide a stable emulsion cosmetic comprising ceramides.

In another aspect, a problem to be solved by the present invention is to provide an emulsified cosmetic composition having excellent skin stability.

From another viewpoint, the problem to be solved by the present invention is to stably maintain the ceramide inside the large emulsion particle, and the ceramide of the trauma is also stable crystal surrounded by the amphipathic anisotropic powder, uniformly dispersed without any unevenness among the ceramide particles, To provide a formulation having a soft feeling without foreign bodies and an emulsified cosmetic composition excellent in emulsion stability.

In another aspect, a problem to be solved by the present invention is to provide an emulsified cosmetic composition which is uniformly dispersed evenly among ceramides even when the ceramides are contained in a high content, and is excellent in formulation and emulsion stability.

In another aspect, a problem to be solved by the present invention is to provide an emulsified cosmetic composition which can provide a stable formulation without containing an excessive amount of thickening agent.

Another aspect of the present invention is to provide an emulsified cosmetic composition which prevents skin irritation by excluding an excessive amount of a thickening agent, a dispersant, a surfactant, and the like.

Another aspect of the present invention is to provide a cosmetic composition for emulsifying, which exhibits a unique feeling of use and a moisturizing effect due to bursting of emulsified particles.

From another viewpoint, a problem to be solved by the present invention is to provide a cosmetic composition for emulsifying which gives a feeling of use that is quick in absorption and soft in release due to its low viscosity.

In one aspect, the present invention is an underwater type emulsified cosmetic composition comprising an amphiphilic anisotropic powder and a ceramide, wherein the amphiphilic anisotropic powder includes a first polymeric spheroid which is hydrophilic and a second polymeric spheroide which is hydrophobic, Wherein the spheroids and the second polymer spheroids are at least partially bound to a structure that penetrates the counterpart polymer spheroids, and wherein the first polymer spheroids and the second polymer spheroids comprise (meth) acrylate-based polymers, Provides an oil-in-water emulsion composition comprising oil-based ceramides contained in an oil phase and ceramide particles contained in the water phase.

In one aspect, the present invention can provide a stable emulsion cosmetic comprising ceramides.

From another point of view, the present invention can provide an emulsified cosmetic composition having excellent skin stability.

From another viewpoint, the present invention stably maintains ceramides inside the large emulsion particles, and the ceramide of the trauma is also stable crystals surrounded by the amphiphilic anisotropic powder, uniformly dispersed without any unevenness among the ceramide particles, And can provide an emulsified cosmetic material excellent in formulation and emulsion stability.

From another point of view, the present invention can provide a cosmetic composition which is uniformly dispersed without any coalescence between ceramides and excellent in formulation and emulsion stability even when ceramide is contained in a high content.

In another aspect, the present invention can provide an emulsified cosmetic composition capable of providing a stable formulation without containing an excessive amount of thickening agent.

From another viewpoint, the present invention can provide an emulsified cosmetic composition that prevents skin irritation by eliminating excessive amounts of an aging agent, a dispersant, a surfactant, and the like.

From another viewpoint, the present invention can provide a cosmetic composition for emulsifying which exhibits a unique feeling of use and moisturizing due to the bursting of emulsified particles.

From another point of view, the present invention can provide a cosmetic composition for emulsifying which gives a feeling of use that is quick in absorption and soft in release due to its low viscosity.

Embodiments of the present application will now be described in more detail with reference to the accompanying drawings. However, the techniques disclosed in the present application are not limited to the embodiments described herein but may be embodied in other forms. It should be understood, however, that the embodiments disclosed herein are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. In the drawings, the widths and thicknesses of components are slightly enlarged in order to clearly illustrate each component. In addition, although only a part of the components is shown for convenience of explanation, those skilled in the art can easily grasp the rest of the components. It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention.

As used herein, unless otherwise defined, at least one hydrogen atom of the functional groups of the invention is optionally substituted with at least one substituent selected from the group consisting of halogen (F, Cl, Br or I), a hydroxy group, a nitro group, an imino group A substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, May be substituted with a substituted heterocycloalkyl group having 2-30 carbon atoms.

As used herein, "(meth) acrylic" may mean acryl and / or methacryl.

The particle size of the amphiphilic anisotropic powder herein is the maximum length measured as the longest length of the powder particle. The particle size range of the amphiphilic anisotropic powder herein means that at least 95% of the amphipathic anisotropic powder present in the composition falls within this range.

In the present specification, the average particle diameter of the emulsified particles means an average value of the diameter of the single particles. In the present specification, the mean particle size range of the emulsified particles means that at least 95% of the emulsified particles present in the composition fall within the above range.

In the present specification, the average particle diameter of the ceramide particles means a volume average particle diameter obtained by calculating the volume average based on the particle size distribution measured by a known particle size distribution measurement method such as electron microscopic image observation, laser diffraction, or the like.

According to one embodiment of the present invention, there is provided an emulsified cosmetic composition comprising a ceramide and an amphiphilic anisotropic powder. The composition according to the present embodiment can provide a cosmetic composition containing ceramides and having excellent skin absorbency and excellent moisturizing effect.

In this embodiment, the emulsifying cosmetic composition may be an oil-in-water (O / W) composition.

In the present embodiment, the ceramide is present in an amount of at least 0.1 wt%, at least 0.2 wt%, at least 0.3 wt%, at least 0.4 wt%, at least 0.5 wt%, at least 0.6 wt%, at least 0.7 wt% At least 0.9% by weight, at least 1.0% by weight, at least 1.1% by weight, at least 1.2% by weight, at least 1.3% by weight, at least 1.4% by weight, at least 1.5% by weight, at least 1.6% by weight, at least 1.7% At least 1.9 wt%, at least 2.0 wt%, at least 2.1 wt%, at least 2.2 wt%, at least 2.3 wt%, at least 2.4 wt%, at least 2.5 wt%, at least 2.6 wt%, at least 2.7 wt% At least 3% by weight, at least 3.1% by weight, at least 3.2% by weight, at least 3.3% by weight, at least 3.4% by weight, at least 3.5% by weight, at least 3.6% by weight, at least 3.7% , Not more than 3.9 wt%, or not less than 4 wt%, and not more than 30 wt%, not more than 29.5 wt%, not more than 29 wt%, not more than 28.5 wt%, not more than 28 wt% 25% by weight or less, 25% by weight or less, 24.5% by weight or less, 24% by weight or less, 23.5% by weight or less, 23% by weight or less, 22.5% by weight % Or less, 22 wt% or less, 21.5 wt% or less, 21 wt% or less, 20.5 wt% or less, 20 wt% or less, 19.5 wt% or less, 19 wt% or less, 18.5 wt% or less, 18 wt% 15% by weight or less, 15% by weight or less, 14.5% by weight or less, 14% by weight or less, 13.5% by weight or less, 13% by weight or less, 12.5% by weight Or less, 12 wt% or less, 11.5 wt% or less, 11 wt% or less, 10.5 wt% or less, 10 wt% or less, 9.5 wt% or less, 9 wt% or less, 8.5 wt% or less, or 8 wt% . For example, the ceramide may be present in an amount ranging from 0.1% to 30%, 0.5% to 20%, 0.5% to 10%, 1% to 12%, 2% to 10% , Or from 4% to 8% by weight. Within this range, the formulation stability is excellent and skin moisturizing and absorption ability can be improved.

In one example, the ceramide may be partly or wholly contained in the oil phase. The oil-based ceramide contained in the oil phase is present in the emulsion particle forming a solid interface film to form a stable emulsion formulation, and can provide a unique feeling of use due to particle bursting due to the inner emulsion particle ejection during skin application.

In one example, the ceramide may be partly or wholly contained in the water. The ceramide contained in the water phase is surrounded by an amphipathic anisotropic powder to form a crystal form, which is referred to as a ceramide particle in the present specification. The ceramide particles are stably present in the aqueous phase without intermixing the particles. The microceraide particles formed by mixing with the anisotropic powder can provide a soft feel without a foreign body by crystal upon application.

The ceramide particles may be contained in a proportion of 50% by weight to 95% by weight based on the total weight of the ceramides including the oil-based ceramide and the ceramide particles. Within the above-mentioned range, the composition has excellent absorption power and can provide a feeling of soft feeling.

The ceramide particles may have an average particle diameter of 5 mu m to 200 mu m. Within this range, a feeling of soft feeling can be exhibited without a foreign object.

In one embodiment, the ceramide may use one or more of natural ceramide and pseudoceramide.

For example, the pseudoceramide may include, but not limited to, one or more of the compounds represented by the following formulas (1) to (5).

≪ Formula 1 >

Figure pat00001

(Wherein, R is a saturated or unsaturated aliphatic chain of C 9 -C 21.)

(2)

Figure pat00002

(Wherein n is 1 or 2;

R and R 'is a saturated or unsaturated aliphatic chain of C 9 -C 21.)

(3)

Figure pat00003

(Wherein,

m and n are the same or different and are an integer of 1 to 3;

k and l are the same or different and are 1 or 2;

j is 0 or 1;

R and R 'are the same or different and are a linear or branched, saturated or unsaturated alkyl group of C 1 -C 31 , which contains or does not contain a hydroxyl group;

A 1 , A 2 and A 3 are the same or different and are hydrogen or any substituent of the following structure, provided that A 1 , A 2 and A 3 are simultaneously hydrogen:

Figure pat00004

Wherein M, M 1 and M 2 are selected from the group consisting of alkali metals, lysine, arginine, histidine, triethanolamine, ammonia, polyquaternium-4, polyquaternium-6, polyquaternium- L is selected from the group consisting of polyquaternium-11, polyquaternium-16, lauryldimethylbenzylammonium chloride and stearyldimethylbenzylammonium chloride, and L is an alkaline earth metal)

≪ Formula 4 >

Figure pat00005

(Wherein R, R and R 'are the same or different, which does not contain or contains a hydroxy group, C 10- C 32 linear or branched and saturated or unsaturated alkyl group;

R 3 and R 4 are the same or different and are hydrogen or a C 1 -C 4 alkyl or hydroxyalkyl group;

R 5 is -A or -CH 2 CH 2 OA, is one where the substituent is any of the following structures A.

Figure pat00006

Wherein M, M 1 and M 2 are selected from the group consisting of alkali metals, lysine, arginine, histidine, triethanolamine, ammonia, polyquaternium-4, polyquaternium-6, polyquaternium- L is selected from the group consisting of polyquaternium-11, polyquaternium-16, lauryldimethylbenzylammonium chloride and stearyldimethylbenzylammonium chloride, and L is an alkaline earth metal)

≪ Formula 5 >

Figure pat00007

Wherein m and n are the same or different and are an integer from 1 to 4; R and R 'are the same or different and are selected from the group consisting of C 1 -C 31 linear or branched saturated or unsaturated Alkyl group;

A 1 and A 2 are the same or different and are either hydrogen or a substituent of the following structure;

Figure pat00008

Wherein M, M 1 and M 2 are selected from the group consisting of alkali metals, lysine, arginine, histidine, triethanolamine, ammonia, polyquaternium-4, polyquaternium-6, polyquaternium- Polyquaternium-11, polyquaternium-16, lauryldimethylbenzylammonium chloride and stearyldimethylbenzylammonium chloride, and L is an alkaline earth metal.

In this embodiment, the amphiphilic anisotropic powder comprises a first polymeric spheroid that is hydrophilic and a second polymeric spheroide that is hydrophobic, wherein the first polymeric sphereoid and the second polymeric sphereoid are at least partially composed of an opposite polymeric sphereoid And the first polymer spolide and the second polymer spolide may include a (meth) acrylate-based polymer.

As used herein, the term "spheroid" refers to a body made of a polymer, for example, a sphere, a globoid, or an oval shape, Or may have a long axial length of nano units.

According to one exemplary embodiment, the (meth) acrylate-based polymer may comprise a polymer of a (meth) acrylate-based monomer having an alkyl group.

According to one exemplary embodiment, the (meth) acrylate-based monomer having an alkyl group may include an unsubstituted (meth) acrylic acid ester having a linear or branched alkyl group having 1 to 20 carbon atoms. (Meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, n-butyl (meth) acrylate, (Meth) acrylate, hexyl (meth) acrylate, heptyl (meth) acrylate, ethylhexyl (meth) acrylate, octyl Acrylate, decyl (meth) acrylate, lauryl (meth) acrylate, and the like.

In one embodiment, the first polymer spolide may further include a hydrophilic functional group.

For example, the hydrophilic functional group may be a functional group having a negative or positive charge or a polyethylene glycol (PEG) group, and may be a carboxylic acid group, a sulfonic group, a phosphate group, an amino group, an alkoxy group, an ester group, an acetate group, a polyethylene glycol group, And the like.

In one embodiment, the first polymer spolide may further include a sugar-containing functional group.

In one embodiment, the functional group containing the sugar is selected from the group consisting of N- {N- (3-triethoxysilylpropyl) aminoethyl} gluconamide, N- (3-triethoxysilylpropyl) - (3-triethoxysilylpropyl) aminoethyl} -oligo-hyaluronamide, and the like.

In one embodiment, the amphiphilic anisotropic powder may have a symmetrical shape, an asymmetric snowman shape, or an asymmetric inverse snowman shape based on the joint where the first polymer spoloid and the second polymer spoloid are combined. The shape of the snowman means that the first and second polymer spheroids having different sizes are combined.

In one example, the amphiphilic anisotropic powder may have a particle size of 100 to 2500 nm. In another aspect, the amphiphilic anisotropic powder may have a particle size of 100 to 1500 nm, 100 to 500 nm, or 200 to 300 nm. Specifically, the amphiphilic anisotropic powder preferably has a particle size of 100 nm or more, 200 nm or more, 300 nm or more, 400 nm or more, 500 nm or more, 600 nm or more, 700 nm or more, 800 nm or more, 900 nm or more, Or less, and 2500 nm or less, 2400 nm or less, 2300 nm or less, 2200 nm or less, 2100 nm or less, 2000 nm or less, 1900 nm or less Less than 1,100 nm, less than 1,100 nm, less than 1,000 nm, less than 900 nm, less than 800 nm, less than 700 nm, 600 nm or less, 500 nm or less, 400 nm or less, 300 nm or less, or 200 nm or less.

In one example, the amphiphilic anisotropic powder may form macroporous emulsion particles of 2 to 500 mu m. In another aspect, the amphiphilic anisotropic powder may be one that forms macromolecular emulsion particles of from 5 to 400 microns, from 10 to 350 microns, from 30 to 300 microns, or from 50 to 300 microns. Specifically, the amphiphilic anisotropic powder may have an average particle diameter of 2 탆 or more, 3 탆 or more, 4 탆 or more, 5 탆 or more, 6 탆 or more, 7 탆 or more, 8 탆 or more, 9 탆 or more, 10 탆 or more, At least 15 탆, at least 16 탆, at least 17 탆, at least 18 탆, at least 19 탆, at least 20 탆, at least 21 탆, at least 22 탆, at least 23 탆, at least 24 탆 At least 25 mu m, at least 26 mu m, at least 27 mu m, at least 28 mu m, at least 29 mu m, at least 30 mu m, at least 31 mu m, at least 32 mu m, at least 33 mu m, at least 34 mu m, at least 35 mu m, at least 36 mu m, at least 37 At least 40 탆, at least 41 탆, at least 42 탆, at least 43 탆, at least 44 탆, at least 45 탆, at least 46 탆, at least 47 탆, at least 48 탆, at least 49 탆 , Or 50 占 퐉 or more, and 500 占 퐉 or less, 490 占 퐉, 480 占 퐉, 470 占 퐉, 460 占 퐉, 450 占 퐉, 440 占 퐉, 430 占 퐉, 420 占 퐉, 410 占 퐉, , 390 탆 or less, 380 탆 300 μm or less, 310 μm or less, 300 μm or less, 290 μm or less, 280 μm or less, 270 μm or less, 260 μm or less, It is preferable to form emulsion particles having a particle size of 250 μm or less, 240 μm or less, 230 μm or less, 220 μm or less, 210 μm or less, 200 μm or less, 190 μm or less, 180 μm or less, 170 μm or less, 160 μm or less .

The hydrophobic portion and the hydrophilic portion of the amphipathic anisotropic powder have different orientations toward the interface, whereby the macro emulsion particles can be formed. It is possible to provide emulsified formulations having various viscosities including the formulations having the soft feel of low viscosity with the large emulsified particles as described above.

While the interface film formed by a general molecular level surfactant forms a dynamic emulsification state, the emulsion particle formed by the amphiphilic anisotropic powder increases the thickness of the interfacial film to several hundreds nm and forms a solid interfacial film . Through the formation of the interfacial film, the stability of emulsification is improved and a stable emulsified state can be maintained without being affected by ceramides. Further, amorphous anisotropic powders which are present in the external phase precipitated from the internal phase or not captured in the emulsion particles are surrounded by crystals to form stable ceramide particles, and such ceramide particles do not affect the interface film of the emulsified particles , The composition can be uniformly dispersed in the composition to maintain a stable composition.

In one embodiment, the composition comprises the amphiphilic anisotropic powder in an amount of, for example, at least 0.1%, at least 0.2%, at least 0.3%, at least 0.4%, at least 0.5%, at least 0.6% , Not less than 0.7 wt%, not less than 0.8 wt%, not less than 0.9 wt%, or not less than 1.0 wt%, not more than 30 wt%, not more than 29 wt%, not more than 28 wt%, not more than 27 wt% % Or less, 24 wt% or less, 23 wt% or less, 22 wt% or less, 21 wt% or less, 20 wt% or less, 19 wt% or less, 18 wt% or less, 17 wt% or less, 16 wt% 14% or less, 13% or less, 12% or less, 11% or less, 10% or less, 9% or less, 8% or less, 7% or less, 6% Or less, 4 wt% or less, or 3 wt% or less. For example, the amphiphilic anisotropic powder may contain 0.1% to 10% by weight based on the total weight of the composition. Stable emulsion particles can be formed within the above range, and emulsion particles having an appropriate size can be formed.

The composition according to this embodiment may have a viscosity of, for example, at least 1000 cps, at least 1100 cps, at least 1200 cps, at least 1300 cps, at least 1400 cps, at least 1500 cps, at least 1600 cps, at least 1700 cps, at least 1800 cps , Not less than 1900 cps, not less than 2000 cps, not less than 2100 cps, not less than 2200 cps, not less than 2300 cps, not less than 2400 cps, or not less than 2500 cps, not more than 30,000 cps, not more than 29000 cps, not more than 28000 cps, not more than 27000 cps, not more than 26000 cps Less than 25000 cps, less than 24000 cps, less than 23000 cps, less than 22000 cps, less than 21000 cps, less than 20,000 cps, less than 19000 cps, less than 18000 cps, less than 17000 cps, less than 16000 cps, less than 15000 cps, less than 14000 cps, 13000 8000 cps or less, 8000 cps or less, 8000 cps or less, 8000 cps or less, 8000 cps or less, 8000 cps or less, , 8000 cps or less, 7900 cps or less, 7800 cps or less, 7700 cps or less, 7600 cps or less, 7500 cps or less, 7400 cp less than 7000 cps, less than 7000 cps, less than 6000 cps, less than 6000 cps , 6100 cps or less, or 6000 cps or less. For example, the viscosity may be 1,000 to 30,000 cps, 1,000 cps to 20,000 cps, 1,500 cps to 10,000 cps, or 2,000 cps to 7,000 cps. The composition according to the present embodiment can form macroporous emulsion particles having emulsion interface including emulsion ceramides and a single amphipathic anisotropic powder not forming emulsion particles are also present in the trauma so that the ceramide particles present in the trauma are precipitated, And the emulsion stability of the formulation can be also excellent.

The composition according to the present embodiment can maintain the stability of the emulsified form without containing any additional thickening agent or wax, even when containing ceramides in a high content, so that it is possible to provide the above wide range of viscosity compositions. Even when the ceramide is contained in a high content, it is possible to produce a composition having a low viscosity, for example, a viscosity of 8,000 cps or less, 7,000 cps or less, or 4,000 cps to 7,000 cps. A flowable flexible formulation can be provided within the above range, so that a fresh feeling without feeling of tackiness can be exhibited.

The method for producing a cosmetic composition according to an embodiment of the present invention may include preparing the amphiphilic anisotropic powder and emulsifying the oil phase and the water phase using the amphoteric anisotropic powder produced.

 In one embodiment of the present invention, the amphiphilic anisotropic powder is prepared by (1) stirring a first monomer and a polymerization initiator to prepare a first polymer spoloid; And (2) stirring the prepared first polymer spoloid with a second monomer and a polymerization initiator to prepare an anisotropic powder having a second polymer spoloid formed thereon.

In one example, the method may further include (3) introducing a hydrophilic functional group into the anisotropic powder prepared above after the anisotropic powder of (2) is produced.

In the above steps (1), (2) and (3), stirring may be rotary stirring. It is preferable to rotate and stir because chemical mechanical modification and homogeneous mechanical mixing are required for producing uniform particles. The rotational stirring may be performed in a cylindrical rotating reactor, but the rotational stirring method is not limited thereto.

At this time, the design inside the reactor has a great influence on powder formation. The size and location of the baffles in the cylindrical rotating reactor and the degree of spacing between the impeller and the baffles greatly influence the uniformity of the particles produced. It is desirable to minimize the interval between the blades of the inner wing and the impeller to equalize the convection flow and the strength thereof, and to feed the powder reaction liquid below the wing length and to maintain the impeller rotation speed at a high speed. 200 rpm, and the length to diameter ratio of the reactor may be 1 to 3: 1 to 5, more specifically 10 to 30 cm in diameter and 10 to 50 cm in height. The reactor size can be varied in proportion to the reaction capacity. The material of the cylindrical rotating reactor may be ceramics, glass, etc., and the temperature at the time of stirring is preferably 50 to 90 ° C.

In the cylindrical rotating reactor, the simple rotation method is capable of producing uniform particles, and is a low energy method requiring less energy and maximizing the reaction efficiency, enabling mass production. The conventional tumbling method in which the reactor itself rotates requires high energy and restricts the size of the reactor since the entire reactor must be tilted at a constant angle and rotated at high speed. The amount produced due to reactor size limitations was also limited to small quantities of the order of several hundreds of milligrams to several grams, making them unsuitable for mass production.

According to one exemplary embodiment, the first monomer and the second monomer may be the same or different, and specifically may be (meth) acrylate-based monomers. The polymerization initiator used in each step may be the same or different, and the cross-linking agent used in each step may be the same or different.

According to one exemplary embodiment, the (meth) acrylate-based monomer may include an unsubstituted (meth) acrylate ester having a linear or branched alkyl group having 1 to 20 carbon atoms. (Meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, n-butyl (meth) acrylate, (Meth) acrylate, hexyl (meth) acrylate, heptyl (meth) acrylate, ethylhexyl (meth) acrylate, octyl Acrylate, decyl (meth) acrylate, lauryl (meth) acrylate, and the like, for example, methyl methacrylate.

In one example, the polymerization initiator may be a radical polymerization initiator, specifically, a peroxide type, an azo type, or a mixture thereof. Ammonium persulfate, sodium persulfate and potassium persulfate may also be used. For example, the polymerization initiator may be azobisisobutyronitrile, but is not limited thereto.

According to an exemplary embodiment, the first monomer and the polymerization initiator in (1) may be mixed in a weight ratio of 100 to 1000: 0.1 to 2. [ In another aspect, the first monomer and the polymerization initiator may be mixed in a weight ratio of 100 to 750: 1, or 100 to 500: 1, or 100 to 250: 1.

In another aspect, the first monomer, the polymerization initiator and the crosslinking agent may be added in the above (1). The first monomer, the polymerization initiator and the crosslinking agent may be mixed at a weight ratio of 80: 150: 0.5 to 2: 0.5 to 2, for example, 100: 1: 1.

According to one exemplary embodiment, the cross-linking agent may be a (meth) acrylate-based cross-linking agent and may be one or more of, for example, allyl methacrylate and ethylene glycol dimethacrylate , Specifically allyl methacrylate.

The size and shape of the amphiphilic anisotropic powder are influenced by the adjustment of the first polymer spoil size of the initial (1), and the first polymer spoil size can be adjusted according to the weight ratio of the first monomer, the polymerization initiator and the crosslinking agent. In addition, by mixing at the weight ratio within the above range, there is an effect that the uniformity of the anisotropic powder can be increased.

In another aspect, the first monomer, the polymerization initiator, and the stabilizer may be added in a weight ratio of 100 to 1000: 1: 0.001 to 20 by further adding a stabilizer in the above (1).

According to one exemplary embodiment, the stabilizer may be an ionic vinyl polymer, and may specifically be at least one of polyvinylpyrollidone and polyvinyl alcohol, for example, polyvinylpyrrolidone It can be a lollydon. The ionic polymer increases the viscosity of the trauma by the expansion of the macromolecular chain and reduces the fluidity of the powder. This makes it possible to prevent the particles produced by the polymer polymerization from becoming entangled and united (bonded) to each other and to maintain a uniform size.

When the amphiphilic anisotropic powder has a size of 300 to 400 nm, the weight ratio of the first monomer, the polymerization initiator and the crosslinking agent is 110 to 130: 1: 1 to 5, specifically 115 to 125: 1: 2 to 4 Can be prepared from the first polymer spolide.

When the amphiphilic anisotropic powder has a size of 1100 to 2500 nm, the weight ratio of the first monomer, the polymerization initiator and the crosslinking agent is 100 to 150: 0.5 to 2: 0 to 2, specifically, 115 to 125: 1: 0 Can be prepared from the first polymer spolide.

The asymmetric snowman-like amphiphilic anisotropic powder is preferably an amphoteric anisotropic powder whose weight ratio of the first monomer, the polymerization initiator and the crosslinking agent is 100 to 200: 0.1 to 1: 5 to 15, specifically 110 to 130: 1: 9 to 11 1 < / RTI > polymer spolide.

The amphiphilic anisotropic powder having an asymmetric reverse snowman shape is preferably an amorphous amorphous powder having a weight ratio of the first monomer, the polymerization initiator and the crosslinking agent of 100 to 200: 1: 1 to 10, specifically 110 to 130: 1: 2 to 4 Can be prepared from polymeric sphereoids.

According to an exemplary embodiment, the second monomer and the polymerization initiator in (2) may be mixed in a weight ratio of 100 to 300: 1. In another aspect, the second monomer and the polymerization initiator may be present in an amount of from 160 to 250: 1, or from 170 to 250: 1, or from 180 to 250: 1, or from 190 to 250: 1, or from 200 to 250: : 1, or 220 to 250: 1, or 230 to 250: 1, or 240 to 250: 1.

In another aspect, the second monomer, the polymerization initiator and the cross-linking agent may be mixed in a weight ratio of 100 to 300: 1: 0.001 to 10 by further adding a cross-linking agent in the step (2). By mixing at a weight ratio within the above range, uniformity of the anisotropic powder can be enhanced.

According to one exemplary embodiment, the cross-linking agent may be a (meth) acrylate-based cross-linking agent and may be one or more of, for example, allyl methacrylate and ethylene glycol dimethacrylate , Specifically ethylene glycol dimethacrylate.

In another aspect, the stabilizer may further be added in the step (2) to mix the first monomer, the polymerization initiator and the stabilizer in a weight ratio of 100 to 1000: 1: 0.001 to 20.

According to one exemplary embodiment, the stabilizer may be an ionic vinyl polymer, and specifically may be at least one of polyvinylpyrollidone and polyvinyl alcohol, for example, polyvinyl alcohol Lt; / RTI >

According to one exemplary embodiment, the second monomer content in step (2) may be 40 to 300 parts by weight when the first polymer spoil weight is 100 parts by weight. Specifically, if the second monomer content is in the range of 20 to 100 parts by weight based on 100 parts by weight of the first polymer spoil, the asymmetric snowman type powder is obtained, and when 100 to 150 parts by weight or 110 to 150 parts by weight, , 150 to 300 parts by weight, or 160 to 300 parts by weight, an asymmetric reverse snowman type powder is obtained. In addition, by mixing at the weight ratio within the above range, there is an effect that the uniformity of the anisotropic powder can be increased.

According to one exemplary embodiment, the hydrophilic functional group in (3) above may be introduced using a silane coupling agent and a reaction modifier, though not limited thereto.

According to one exemplary embodiment, the silane coupling agent is selected from the group consisting of (3-aminopropyl) trimethoxysilane, N- [3- (trimethoxysilyl) propyl] ethylenediamine, N- [3- ) Propyl] ethylenediammonium chloride, (N-succinyl-3-aminopropyl) trimethoxysilane, 1- [3- (trimethoxysilyl) propyl] urea and 3 - [(trimethoxysilyl) ] -1,2-propanediol, and specifically may be at least one selected from the group consisting of N- [3- (trimethoxysilyl) propyl] ethylenediamine.

According to one exemplary embodiment, the silane coupling agent may be mixed in an amount of 35 parts by weight to 65 parts by weight, for example, 40 parts by weight to 60 parts by weight, based on 100 parts by weight of the anisotropic powder produced in the step (2) . Within this range, hydrophilization can be appropriately performed.

According to one exemplary embodiment, the reaction modifier may be ammonium hydroxide.

According to an exemplary embodiment, the reaction control agent may be mixed with 85 to 115 parts by weight, for example, 90 to 110 parts by weight, based on 100 parts by weight of the anisotropic powder prepared in (2). Within this range, hydrophilization can be appropriately performed.

In another embodiment of the present invention, in the production of the amphiphilic anisotropic powder according to one embodiment of the present invention, the step (2) is followed by (4) a step of introducing a sugar-containing functional group into the produced anisotropic powder .

In the step (4), the functional group containing sugar is not limited thereto, but may be introduced using a sugar-containing silane coupling agent and a reaction control agent.

According to one exemplary embodiment, the sugar-containing silane coupling agent is selected from the group consisting of N- {N- (3-triethoxysilylpropyl) aminoethyl} gluconamide, N- (3-triethoxysilylpropyl) And N- {N- (3-triethoxysilylpropyl) aminoethyl} -oligo-hyaluronamide.

According to one exemplary embodiment, the reaction modifier may be ammonium hydroxide.

For example, the reaction modifier may be added in an amount of 85 to 115 parts by weight, for example, 90 to 110 parts by weight based on 100 parts by weight of the anisotropic powder prepared in the step (2). The introduction of a sugar-containing functional group within the above range can be suitably performed.

The preparation of the amphiphilic anisotropic powder according to the above method does not use a cross-linking agent, so there is no production entanglement. Thus, the yield is high and uniform, and mass production is easier than the tumbling method using a simple agitation method. In particular, there is an advantage that a nano size of 300 nm or less can be mass-produced in a unit of tens g to several tens of kg.

For example, the composition according to the present embodiment can form a formulation which is characterized not only by the conventional water-in-oil type, but also by the granular emulsified particles. The composition according to this embodiment can uniformly disperse the ceramide without using a high amount of the thickening agent, thereby preventing stickiness and skin irritation due to the thickening agent.

The composition according to the present embodiment can provide a feeling of feeling that the formulation can be easily collapsed when the skin is applied and smoothly spread.

The composition according to this embodiment can also prevent skin irritation, which may be caused by the addition of a dispersant or an excessive amount of a surfactant.

The composition according to the present embodiment is excellent in emulsion stability in an emulsified formulation, including ceramides, and can impart a flexible feeling of use as an emulsified composition, a skin-absorbing power and a moisturizing effect at the same time. In particular, even in the presence of a high content of ceramide, the stability is not affected and the above-mentioned effect can be exhibited.

The composition according to this embodiment can eliminate the sticky finish feeling due to the surfactant and can provide a matte and powdery finish to the formulation by the presence of the amphiphilic anisotropic powder that does not form emulsified particles.

The composition according to this embodiment may exhibit emulsion stability over time in a wide temperature range, for example, from -15 캜 to 60 캜, for example, from -10 캜 to 55 캜.

The composition according to this embodiment can contain a large emulsion particle to provide a soft and soft feel.

The cosmetic composition according to embodiments of the present invention may be formulated containing a cosmetically or dermatologically acceptable medium or base. It may be in the form of a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome) and a non-ionic follicular dispersion, or a cream, a skin, a lotion, a powder, an ointment, a spray, May be provided in the form of a stick. It can also be used in the form of a foam or in the form of an aerosol composition further containing a compressed propellant. These compositions may be prepared according to conventional methods in the art.

In addition, the cosmetic composition according to embodiments of the present invention may be in the form of powders, fatty substances, organic solvents, solubilizers, thickeners, gelling agents, softeners, antioxidants, suspending agents, stabilizers, foaming agents, , Water, ionic or nonionic emulsifiers, fillers, sequestering agents, chelating agents, preservatives, vitamins, barrier agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics And any other ingredients used, such as cosmetics or adjuvants commonly used in the field of dermatology. Such adjuvants are introduced in amounts commonly used in the cosmetics or dermatological fields. The cosmetic composition according to the embodiments of the present invention may further contain a skin absorption promoting substance to increase the skin improving effect.

Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not construed as being limited by these embodiments.

[ Manufacturing example  1-3] Amphipathic  Anisotropy Powdery  Produce

Manufacturing example  One. Polymethyl methacrylate (PMMA) first polymer Speroid  Produce

(PVP, Mw 360,000) as a stabilizer were mixed to prepare a dispersion solution. 10 g of methyl methacrylate, 0.1 g of azobisisobutyronitrile (AIBN) 0.1 as a polymerization initiator, g alc 0.1 g of allyl methacrylate as a crosslinking agent were mixed to prepare a monomer solution. The monomer solution was added to the dispersion solution, purged with nitrogen for 30 minutes, and reacted at 62 DEG C for 12 hours. The reaction was stirred in a cylindrical rotating reactor. The cylindrical rotating reactor was 11 cm in diameter, 17 cm in height, made of glass, and rotated at a speed of 500 rpm.

Methanol was added to the first polymer spoloid obtained, washed three times with a centrifuge at 12,000 rpm for 60 minutes, dried at room temperature under a reduced pressure pump, and pulverized with a mortar to obtain a powder. 4 shows an electron micrograph of the first polymer spoloid prepared in FIG.

Manufacturing example  2. Amphipathic  Anisotropy Powder  Produce

37 g of water and 1.38 g of polyvinyl alcohol as a stabilizer are mixed to prepare a dispersion solution. 0.5 g of the first polymer spolide prepared in Preparation Example 1 and the dispersion solution were mixed and mixed at room temperature and 500 rpm for one hour. 5.0 g of methyl methacrylate, 0.5 g of ethylene glycol dimethacrylate as a crosslinking agent, And 0.05 g of azobisisobutyronitrile as a polymerization initiator were added, and the mixture was allowed to react at normal temperature and 500 rpm for 24 hours. As an inhibitor, 0.025 g of hydroquinone was added and reacted at 75 DEG C and 500 rpm for 24 hours. The reaction was carried out in a cylindrical rotating reactor, followed by methanol washing three times for 60 minutes at 12,000 rpm in a centrifuge, drying at room temperature by a reduced pressure pump, and pulverizing into a pellet. An amphiphilic anisotropic powder of about 350 nm in size was prepared, and a micrograph thereof is shown in Fig. 5 (a).

Manufacturing example  3. Hydrophilization Treated Amphipathic  Anisotropy Powdery  Produce

30 g of N- [3- (trimethoxysilyl) propyl] ethylenediamine (N- [3- (Trimethoxysilyl) propyl] ethylenediamine) as a silane coupling agent was added to 600 g of the aqueous dispersion solution of the amphoteric anisotropic powder obtained in Preparation Example 2 And 60 g of ammonium hydroxide (Ammonium hydroxide) as a reaction modifier were mixed and reacted at 25 DEG C for 24 hours to introduce a hydrophilic functional group. The reaction was stirred in a cylindrical rotating reactor. The compounds used as the silane coupling agent are shown in Table 1.

Figure pat00009

Claims (17)

An amphiphilic anisotropic powder and a ceramide,
The amphiphilic anisotropic powder may be an amorphous powder,
A first polymeric spheroid that is hydrophilic and a second polymeric spheroid that is hydrophobic,
Wherein the first polymeric spheroids and the second polymeric spheroids are at least partially bound to a structure that penetrates the counterpart polymeric spheroids,
Wherein the first polymer spolide and the second polymer spolide comprise a (meth) acrylate-based polymer,
Wherein the ceramide comprises an oil-based ceramide contained in an oil phase and a ceramide particle contained in the water phase.
The method according to claim 1,
Wherein the composition comprises from 0.5% to 10% by weight of the ceramide relative to the total weight of the composition.
The method according to claim 1,
Wherein the ceramide particles are formed into a crystalline phase surrounded by an amphipathic anisotropic powder.
The method according to claim 1,
Wherein the ceramide particles are contained in an amount of 50 to 95% based on the total weight of the ceramides.
The method according to claim 1,
Wherein the ceramide particles have an average particle size of from 5 占 퐉 to 200 占 퐉.
The method according to claim 1,
Wherein the composition comprises from 0.1% to 30% by weight of the amphipathic anisotropic powder relative to the total weight of the composition.
The method according to claim 1,
Wherein the composition has a viscosity of from 1000 cps to 10,000 cps.
The method according to claim 1,
Wherein the ceramide is at least one of a natural ceramide and a pseudoceramide.
The method according to claim 1,
(Meth) acrylate-based polymer comprises a polymer of a (meth) acrylate-based monomer having an alkyl group.
10. The method of claim 9,
The (meth) acrylate-based monomer having an alkyl group includes a (meth) acrylic acid ester having an unsubstituted linear or branched alkyl group having 1 to 20 carbon atoms.
The method according to claim 1,
Wherein the amphipathic anisotropic powder has a symmetrical shape, an asymmetric snowman shape or an asymmetric inverted snowman shape with respect to the joint where the first polymeric spheroid and the second polymeric spheroid are bonded.
The method according to claim 1,
Wherein the amphiphilic anisotropic powder has a particle size of 100 to 2500 nm.
The method according to claim 1,
Wherein the amphiphilic anisotropic powder forms macroparticulate particles having an average particle size of 50 to 300 탆.
The method according to claim 1,
Wherein the first polymeric spheroids are additionally introduced with hydrophilic functional groups.
15. The method of claim 14,
Wherein the hydrophilic functional group is at least one selected from the group consisting of a carboxylic acid group, a sulfonic group, a phosphate group, an amino group, an alkoxy group, an ester group, an acetate group, a polyethylene glycol group and a hydroxyl group.
The method according to claim 1,
Wherein the first polymeric spheroid is further introduced with a functional group containing a sugar.
17. The method of claim 16,
The functional groups containing the sugar include N- {N- (3-triethoxysilylpropyl) aminoethyl} gluconamide, N- (3-triethoxysilylpropyl) -Triethoxysilylpropyl) aminoethyl} -oligo-hyaluronamide. ≪ / RTI >
KR1020150167390A 2015-11-27 2015-11-27 Emulsion type cosmetic composition comprising ceramide KR20170062043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020150167390A KR20170062043A (en) 2015-11-27 2015-11-27 Emulsion type cosmetic composition comprising ceramide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150167390A KR20170062043A (en) 2015-11-27 2015-11-27 Emulsion type cosmetic composition comprising ceramide

Publications (1)

Publication Number Publication Date
KR20170062043A true KR20170062043A (en) 2017-06-07

Family

ID=59223302

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150167390A KR20170062043A (en) 2015-11-27 2015-11-27 Emulsion type cosmetic composition comprising ceramide

Country Status (1)

Country Link
KR (1) KR20170062043A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108272648A (en) * 2018-03-26 2018-07-13 上海蔻沣生物科技有限公司 Cosmetics powder, oil pastes and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108272648A (en) * 2018-03-26 2018-07-13 上海蔻沣生物科技有限公司 Cosmetics powder, oil pastes and preparation method thereof

Similar Documents

Publication Publication Date Title
KR20150138096A (en) Cosmetic composition comprising amphiphilic anisotropic particles and method for manufacturing the same
KR102076003B1 (en) Bi-continuous emulsion type composition comprising AMPHIPHILIC ANISOTROPIC PARTICLES
US10709656B2 (en) Emulsion cosmetic composition containing ceramide and method for preparing same
KR101889327B1 (en) Hybrid emulsion composition comprising different emulsion particle size and method for manufacturing the same
KR101924410B1 (en) Chemically anisotropic particles and cosmetic composition comprising the same
KR20170062043A (en) Emulsion type cosmetic composition comprising ceramide
KR102088804B1 (en) Oil-in-water type emulsion composition comprising emulsion particle cluster and method preparing the same
KR20170062037A (en) Emulsion type cosmetic composition comprising light interference pigment
KR102088803B1 (en) Silicone-in-water type emulsion cosmetic composition comprising silicone oil
KR102645441B1 (en) A emulsion type composition of enhanced stability comprising amphiphilic anisotropic particles
KR20170062020A (en) Emulsion type cosmetic composition comprising wax microparticles
KR20170061977A (en) Emulsion type cosmetic composition comprising polar organic solvent
KR20170062026A (en) Emulsion type cosmetic composition comprising solid butter
KR20170062127A (en) Emulsion type cosmetic composition comprising pigment particles
KR20180033801A (en) Oil-in-water emulsion type cosmetic composition comprising inorganic salt
KR20170062166A (en) Silicone-in-water type emulsion cosmetic composition comprising silicone oil
KR20170062136A (en) Bi-continuous emulsion type composition comprising AMPHIPHILIC ANISOTROPIC PARTICLES
KR102051560B1 (en) Emulsion type cosmetic composition comprising solid butter
KR102080035B1 (en) Emulsion type cosmetic composition comprising pigment particles
KR20170061966A (en) Emulsion type cosmetic composition comprising inorganic UV blocking agent
KR102050397B1 (en) Emulsion type cosmetic composition comprising polar organic solvent
KR20170062061A (en) Surface-modified amphiphilic anisotropic particles and emulsion composition comprising the same and method for manufacturing the same
KR20170062044A (en) (meth)acryl cosmetic composition comprising amphiphilic anisotropic particles and method for manufacturing the same
KR20170062058A (en) Chemically anisotropic particles and cosmetic composition comprising the same
KR20170062057A (en) Hybrid emulsion composition comprising different emulsion particle size and method for manufacturing the same